|Other Names||GDNF family receptor alpha-4, GDNF receptor alpha-4, GDNFR-alpha-4, GFR-alpha-4, Persephin receptor, GFRA4|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13249c was selected from the Center region of GFRA4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Receptor for persephin. Mediates the GDNF-induced autophosphorylation and activation of the RET receptor. May be important in C-cell development and, in the postnatal development of the adrenal medulla.|
|Cellular Location||Isoform GFRalpha4a: Cell membrane; Lipid- anchor, GPI-anchor Isoform GFRalpha4c: Secreted.|
|Tissue Location||Predominantly expressed in the adult thyroid gland. Low levels also found in fetal adrenal and thyroid glands|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is a member of the GDNFreceptor family. It is a glycosylphosphatidylinositol(GPI)-linkedcell surface receptor for persephin, and mediates activation of theRET tyrosine kinase receptor. This gene is a candidate gene forRET-associated diseases. Alternatively spliced transcript variantsencoding different isoforms have been described for this gene.
Yang, J., et al. FEBS Lett. 569 (1-3), 267-271 (2004) :Borrego, S., et al. J. Med. Genet. 40 (3), E18 (2003) :Deloukas, P., et al. Nature 414(6866):865-871(2001)Zhou, B., et al. Pediatr. Neurol. 25(2):156-161(2001)Lindahl, M., et al. J. Biol. Chem. 276(12):9344-9351(2001)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.